BioLife Solutions (BLFS) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $17.19 --0%
EPS Growth %: -6.3%
Financial Fact:
Research and development: 496.87K
Today's EPS Names:
DGICA, UXIN, TOWN, More
EPS Growth %: -6.3%
Financial Fact:
Research and development: 496.87K
Today's EPS Names:
DGICA, UXIN, TOWN, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q2 EPS of ($0.08), $0.02 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $1.6 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bristol-Myers Squibb (BMY) stock slips despite earnings beat
- American Airlines (AAL) Misses Q1 EPS by 7c, Guidance Beats
- Expro Group Holdings N.V. (XPRO) Reports In-Line Q1 EPS, provides guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
